TrialThe Journal of clinical endocrinology and metabolism2019

Efficacy and Safety of Alirocumab 300 mg Every 4 Weeks in Individuals With Type 2 Diabetes on Maximally Tolerated Statin.

Dirk Müller-Wieland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.